Table 3.
Current medications in risk factor groups.
| Total (n = 223) | Group 1 (n = 95) | Group 2 (n = 80) | Group 3 (n = 48) | |
|---|---|---|---|---|
| ACE inhibitors | 43 (19%) | 3 (3%) | 20 (25%) | 20 (42%) |
| Angiotensin II receptor antagonists | 18 (8%) | 4 (4%) | 6 (7%) | 8 (17%) |
| beta-blockers | 27 (12%) | 2 (2%) | 14 (17%) | 11 (23%) |
| Diuretics | 11 (5%) | 3 (3%) | 3 (4%) | 5 (10%) |
| Calcium-channel blockers | 36 (16%) | 3 (3%) | 19 (24%) | 14 (29%) |
| Antiplatelet agents | 28 (12%) | 6 (6%) | 13 (16%) | 9 (19%) |
| Statins | 33 (15%) | 3 (3%) | 12 (15%) | 18 (38%) |
| Antidiabetic agents | 42 (19%) | 7 (7%) | 16 (20%) | 19 (40%) |
| Number of drugs* | 1 [0; 2] | 0 [0; 1] | 1 [0; 2] | 2 [1; 3] |
Data are expressed as number of patients (percentage).
*Number of drugs: sum of all drug classes reported above in the table, presented as median and interquartile range [I; III].
ACE: angiotensin converting enzyme.